SANTA CLARA, Calif., Aug. 19, 2025 /PRNewswire/ — DeepSight Technology, a pioneer in medical imaging, today announced the appointment of Steve Sapot as its new Vice President of Sales. In this role, Mr. Sapot will spearhead the company’s commercial strategy, driving market adoption, partnerships, and customer engagement for DeepSight’s cutting-edge ultrasound solutions, including the NeedleVue™ LC1 Ultrasound System that will work in tandem with the advanced interventional tool guidance and OnPoint™ Imaging that DeepSight is developing.
“We are thrilled to welcome Steve to the DeepSight leadership team,” said Nader Sadrzadeh, Founder and CEO of DeepSight. “Steve brings deep experience in building and leading high-impact commercial organizations, establishing strategic partnerships, and achieving revenue growth in medical technology. His leadership will be instrumental as we gear up for commercialization and broaden our clinical footprint.”
Mr. Sapot brings over a decade of leadership experience across medical device and imaging sectors. Most recently, he held the position of Chief Commercial Officer at Perimeter Medical Imaging AI, where he led its commercial operations from 2020, building market-ready teams and expanding commercial reach. Earlier, he served as Senior Vice President of Medical Sales at Faxitron (a Hologic company), where he managed nationwide capital equipment sales and contributed to launching its Breast Surgery franchise post-acquisition. His career also includes influential commercial roles at ConMed Electrosurgery and Barrx Medical, culminating in leadership across diverse sales and market environments.
“I’m honored to join DeepSight at such a transformative moment,” said Sapot. “The technology here has the potential to redefine interventional ultrasound and tool guidance, and I’m excited to work with the team to bring these innovations to healthcare providers and the patients they serve.”
About DeepSight™ Technology
DeepSight Technology is a leading innovator in medical device technology developing advanced ultrasound solutions including the NeedleVue™ Ultrasound System for enhanced needle and interventional tool guidance along with OnPoint™ Imaging for high-resolution visualization from the tip of a device. DeepSight’s imaging platforms will leverage advanced analytics, proprietary algorithms, novel sensor technology, and state-of-the-art imaging to deliver actionable insights that significantly empower medical professionals and institutions in an innovative way. DeepSight’s mission is to revolutionize patient care through state-of-the-art systems, offering unprecedented precision, clarity and confidence for healthcare providers.
To learn more about DeepSight and NeedleVue™, meet with us at CIRSE 2025 in Barcelona and LSI’25 Europe in London.
For more information, visit www.deepsight.com or contact:
SOURCE DeepSight Technology, Inc.